Enliven Therapeutics Insider Sold Shares Worth $504,903, According to a Recent SEC Filing
() -- Lori Anne Kunkel, Director, on July 06, 2026, sold 10,000 shares in Enliven Therapeutics (ELVN) for $504,903. Following the Form 4 filing with the SEC, Kunkel has control over a total of 41,884 common shares of the company, with 41,884 shares held directly. SEC Filing: Copyright © 2026. All rights reserved. does